In multi-site dermatology groups, one of the most overlooked drains on clinical and administrative time is the manual process of delivering benign pathology results. Each week, teams across locations spend hours delivering the same urgent message: your biopsy came back benign. However, these aren’t complex clinical conversations. They’re routine, repetitive, and ideal for automation. That’s exactly what EliseAI is designed to handle.
EliseAI uses secure, natural-sounding conversational AI to deliver benign results with empathy, speed, and consistency. Our VoiceAI assistant identifies the appropriate patients, verifies their identity, shares a friendly message (“Your results came back benign. No further action is needed.”), and gives them the option to ask questions or request a follow-up. This offloads a meaningful operational burden without compromising care quality
.
This use case applies only to benign results. Malignant or ambiguous findings remain entirely under the care of the physician team. By automating this simple, high-frequency workflow, EliseAI enables staff to spend more time on what matters most—direct patient care.
.svg)
The Real Cost of Manual Benign Result Calls
Most dermatology groups process dozens of pathology reports daily. According to a JAMA Dermatology study, 4 out of 5 lesions referred for suspected malignancy are ultimately benign. That translates to staff spending hours each week repeating the same call—often with added time lost to voicemails, callbacks, and phone tag.
This routine task leads to:
- Staff burnout and turnover: Clinical staff spend time on repetitive phone calls instead of clinical care.
- Inconsistent communication timelines: Some patients hear back quickly; others wait days, leading to anxiety or callbacks.
- Operational inefficiency: Highly trained professionals are diverted from higher-value tasks.
For patients, delayed results cause unnecessary worry and additional outreach. For staff, it adds low-impact work to already full schedules. And for leadership, it signals a breakdown in workflows that should be automated and standardized.
How EliseAI Solves It
EliseAI was built to streamline exactly this kind of process. Our VoiceAI assistant integrates with your EHR and pathology module or results management system to:
- Identify patients with benign results
- Verify identity via phone
- Deliver a friendly, compliant message: “Your biopsy came back benign. No further action is needed.”
- Offer an option to ask a question or schedule a follow-up
EliseAI uses a natural voice that patients trust, operates 24/7, and ensures messages are delivered promptly and consistently. For practices, this means:
- Fewer missed calls and manual follow-ups
- Reduced administrative workload
- Improved staff morale and focus
- Faster communication and a better patient experience
Every interaction is logged and fully documented. Identity is verified, and any follow-up needs are routed appropriately to the clinical team.
Protecting Clinical Time Without Sacrificing Care
EliseAI isn’t a replacement for clinical judgment or sensitive conversations. It is purpose-built to automate benign result communication—nothing more. Malignant results stay in the physician’s hands, where they belong.
By removing this repetitive workflow, as well as scheduling, rescheduling, and cancelling appointments, EliseAI helps practices reduce staff fatigue, streamline follow-ups, and free up resources for higher-value care. Practices already using EliseAI have seen meaningful reductions in callbacks, rework, and routine communication time in their first week.
A Smarter, Scalable Way Forward
Dermatology groups looking to grow efficiently can’t afford to keep clinical staff tied up with repetitive admin tasks. Automating benign result calls with EliseAI is a simple, high-impact way to modernize operations without disrupting care delivery.
If you're looking to reduce burnout, improve consistency, and give your staff back valuable time, EliseAI is here to help. Reach out to schedule a 10-minute walkthrough and we’ll show you exactly how it works—and how quickly you'll see results.